Cargando…

Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression

SIMPLE SUMMARY: Myeloid-derived suppressor cells (MDSC) represent a heterogeneous myeloid cell population that is expanded in tumor bearing hosts and substantially contributes to immunosuppression, representing thereby a valuable therapeutic target. Our study analyzes polymorphonuclear (PMN) and mon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Groth, Christopher, Arpinati, Ludovica, Shaul, Merav E., Winkler, Nina, Diester, Klara, Gengenbacher, Nicolas, Weber, Rebekka, Arkhypov, Ihor, Lasser, Samantha, Petrova, Vera, Augustin, Hellmut G., Altevogt, Peter, Utikal, Jochen, Fridlender, Zvi G., Umansky, Viktor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916588/ https://www.ncbi.nlm.nih.gov/pubmed/33578808 http://dx.doi.org/10.3390/cancers13040726

Ejemplares similares

Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles
por: Arkhypov, Ihor, et al.
Publicado: (2020)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
por: Petrova, Vera, et al.
Publicado: (2020)

Tumor-Derived Factors Differentially Affect the Recruitment and Plasticity of Neutrophils
por: Arpinati, Ludovica, et al.
Publicado: (2021)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
por: Arkhypov, Ihor, et al.
Publicado: (2022)

Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs
por: Lepper, Alisa, et al.
Publicado: (2023)

Immunosuppressive capacity of circulating MDSC predicts response to immune checkpoint inhibitors in melanoma patients
por: Petrova, Vera, et al.
Publicado: (2023)

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression
por: Groth, Christopher, et al.
Publicado: (2018)

Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
por: Fleming, Viktor, et al.
Publicado: (2018)

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
por: Weber, Rebekka, et al.
Publicado: (2018)

Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2
por: Özbay Kurt, Feyza Gül, et al.
Publicado: (2022)

The Bilateral Interplay between Cancer Immunotherapies and Neutrophils’ Phenotypes and Sub-Populations
por: Kaisar-Iluz, Naomi, et al.
Publicado: (2022)

HER3-Receptor-Mediated STAT3 Activation Plays a Central Role in Adaptive Resistance toward Vemurafenib in Melanoma
por: Hüser, Laura, et al.
Publicado: (2020)

IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
por: Weber, Rebekka, et al.
Publicado: (2020)

STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice
por: Bitsch, Rebekka, et al.
Publicado: (2022)

The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
por: Umansky, Viktor, et al.
Publicado: (2016)

Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes
por: Fridlich, Ori, et al.
Publicado: (2023)

Expansion of Polymorphonuclear Myeloid-Derived Suppressor Cells in Patients With Gout
por: Zhong, Limei, et al.
Publicado: (2020)

OR11-2 RNA Sequencing Reveals Unique Transcriptomic Signatures of the Thyroid in a Murine Lung Cancer Model Treated with PD-1 and PD-L1 Antibodies
por: Dresner-Pollak, Rivka, et al.
Publicado: (2022)

RNA Sequencing Reveals Unique Transcriptomic Signatures of the Thyroid in a Murine Lung Cancer Model Treated with PD-1 and PD-L1 Antibodies
por: Pollack, Rena, et al.
Publicado: (2023)

Role of Polymorphonuclear Myeloid‐Derived Suppressor Cells and Neutrophils in Ischemic Stroke
por: Yan, Haomin, et al.
Publicado: (2023)

Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy
por: Raskov, Hans, et al.
Publicado: (2022)

Transcriptomic Analysis Comparing Tumor-Associated Neutrophils with Granulocytic Myeloid-Derived Suppressor Cells and Normal Neutrophils
por: Fridlender, Zvi G., et al.
Publicado: (2012)

Role of STAT3 dependent SOX2 and CD24 expression in melanoma cell adaptive resistance towards targeted therapies
por: Hüser, Laura, et al.
Publicado: (2019)

CD115(−) monocytic myeloid-derived suppressor cells are precursors of OLFM4(high) polymorphonuclear myeloid-derived suppressor cells
por: Zou, Yunyun, et al.
Publicado: (2023)

Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness
por: Predina, Jarrod D, et al.
Publicado: (2012)

CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function
por: Chun, Eunyoung, et al.
Publicado: (2015)

A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells
por: Liu, Haoran, et al.
Publicado: (2018)

Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice
por: Kawano, Tomohiro, et al.
Publicado: (2019)

Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs
por: Hlavaty, Sabina I., et al.
Publicado: (2019)

CD205(+) polymorphonuclear myeloid‐derived suppressor cells suppress antitumor immunity by overexpressing GLUT3
por: Fu, Chenghao, et al.
Publicado: (2021)

Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice
por: Veglia, Filippo, et al.
Publicado: (2021)

Chemotaxis by polymorphonuclear leukocytes
Publicado: (1978)

Immunosenescence of Polymorphonuclear Neutrophils
por: Wessels, Inga, et al.
Publicado: (2010)

A new procedure to analyze polymorphonuclear myeloid derived suppressor cells in cryopreserved samples cells by flow cytometry
por: Sacchi, Alessandra, et al.
Publicado: (2018)

Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia
por: Zahran, Asmaa M., et al.
Publicado: (2021)

Decreased Polymorphonuclear Myeloid-Derived Suppressor Cells and ROS Production Correlated Closely with Bronchopulmonary Dysplasia in Preterm Infants
por: Liu, Wangkai, et al.
Publicado: (2022)

Continuous renal replacement therapy attenuates polymorphonuclear myeloid-derived suppressor cell expansion in pediatric severe sepsis
por: Feng, Shuyun, et al.
Publicado: (2022)

Editorial: Neutrophils in Cancer
por: Segal, Brahm H., et al.
Publicado: (2022)

Reversible pinocytosis in polymorphonuclear leukocytes
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_1i2au6klabioce51s5m9lt86ap